Come up with a name for your new list and we'll add to it:
NeuroGenetic Pharmaceuticals raised a round of funding on December 23, 2011. Investors include
AbbVie Biotech Ventures.
Neurogenetic Pharmaceuticals is a biopharmaceutical discovery and development company focused on developing drug therapies for use in the treatment of neurodegenerative disorders such as Alzheimer's d…